fluorodeoxyglucose f18 has been researched along with Atypical Endometrial Hyperplasia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujibayashi, Y; Kobayashi, M; Mori, T; Okazawa, H; Tsuchida, T; Tsujikawa, T; Yoshida, Y | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
Distinctive FDG and FES accumulation pattern of two tamoxifen-treated patients with endometrial hyperplasia.
Topics: Aged; Aged, 80 and over; Endometrial Hyperplasia; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tamoxifen; Tissue Distribution | 2008 |